| Literature DB >> 32352658 |
Daniela Grimm1,2,3, Markus Wehland2, Thomas J Corydon3,4, Peter Richter5, Binod Prasad5, Johann Bauer6, Marcel Egli7, Sascha Kopp2, Michael Lebert5,8, Marcus Krüger2.
Abstract
A spaceflight has enormous influence on the health of space voyagers due to the combined effects of microgravity and cosmic radiation. Known effects of microgravity (μg) on cells are changes in differentiation and growth. Considering the commercialization of spaceflight, future space exploration, and long-term manned flights, research focusing on differentiation and growth of stem cells and cancer cells exposed to real (r-) and simulated (s-) μg is of high interest for regenerative medicine and cancer research. In this review, we focus on platforms to study r- and s-μg as well as the impact of μg on cancer stem cells in the field of gastrointestinal cancer, lung cancer, and osteosarcoma. Moreover, we review the current knowledge of different types of stem cells exposed to μg conditions with regard to differentiation and engineering of cartilage, bone, vasculature, heart, skin, and liver constructs.Entities:
Keywords: cancer stem cells; microgravity; multicellular spheroids; organoids; random positioning machine; rotating wall vessel; spaceflight; stem cells; tissue engineering
Mesh:
Year: 2020 PMID: 32352658 PMCID: PMC7381804 DOI: 10.1002/sctm.20-0084
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940
FIGURE 1Platforms and devices used for stem cell research under real and simulated microgravity conditions. A, The International Space Station enables long‐term cell culture in real microgravity. B, Custom‐made random positioning machine (RPM) for the cultivation of mammalian cells under simulated microgravity conditions. C, The rotating wall vessel (RWV) is another type of microgravity simulator suitable for suspension cell cultures or adherent cells on microcarrier beads
Summary of selected articles addressing research on cancer stem cells and stem in vitro cultured under simulated microgravity, ordered by organ/tissue
| Cell line | Organ/tissue/cell type | Space or μ | Findings | References |
|---|---|---|---|---|
| H460 | Non‐small cell lung cancer | RPM | Increase in apoptosis, CSCs lost their stemness features, downregulated | Pisanu et al |
| HCT116 | Colorectal cancer | RCCS | CSC; CD133/CD44 dual positive cells, giant cancer cells housing complete nuclear localization of YAP | Arun et al |
|
SAOS‐2, HOS, U2OS T98G, U87MG Du145, LNCap H23 Hep3b Hela Mewo, HO‐1 |
Osteosarcoma Glioblastoma Prostate cancer Lung cancer Hepatocarcinoma Cervical carcinoma Melanoma | HFB | CD133+ cells from cancer cell lines | Kelly et al |
| Rabbit MSCs | Cartilage tissue constructs | RWV | Cartilage nature confirmed by aggrecan and collagen types I and II gene expression as well as by toluidine blue and safranin‐O staining | Ohyabu et al |
| Rabbit adipose‐derived stem cells and bone marrow stromal cells | Cartilage | RCCS, novel cell carrier derived from natural cartilage ECM | Improved the induction of stem cell chondro‐genesis as well as in vivo repair of cartilage lesions in a rabbit model | Yin H et al |
| hMSCs | Bone marrow, osteogenic lineage | RWV | Not suitable for a potential application in cartilage repair | Mayer‐Wagner et al |
| hBMSCs | Bone marrow | ISS | r‐μ | Bradamante et al |
| hADMSCs | Adipose tissue | RPM | Oxygen is a key player for cytoskeletal alterations and modulation of gene expression | Versari et al |
| Rat BMSCs | Bone‐like tissue | STLV bioreactor, chitosan/hydroxyapatite, 28 days | BM‐MSCs‐C/HAp composite microbeads | Koç Demir et al |
| BMSCs | Bone marrow | Clinostat | Depolymerized actin cytoskeleton inhibits osteogenic differentiation of BMSCs through impeding nuclear aggregation of TAZ | Chen et al |
| CD34‐positive human cord blood stem cells (CBSC) | Vascular tubular assemblies | RWV, with or without Cytodex‐3 microcarrier beads and VEGF | Transdifferentiation into the vascular endothelial cell phenotype and assembling into 3D tissue structures | Chiu et al |
| BMSCs | Endothelium‐like cells | Clinostat | Endothelial‐specific molecules (Flk‐1 and vWF) positive | Zhang et al |
| EPCs | PBMNC | 3D clinostat | Most significant increase in CD34+ and double positive Dil‐Ac‐LDL‐FITC‐Ulex‐Lectin cells, both EPC markers. Enhancing the number and angiogenic potential of EPCs | Hagiwara et al |
| Pluripotent stem cell‐derived cardiomyocytes | Heart | ISS | Alterations in hiPSC‐CM calcium handling showed 2635 differentially expressed genes | Wnorowski et al |
| CPCs | Cardiac tissue | ISS, 2D Clinostat | Hippo signaling; upregulation of downstream genes: | Camberos et al |
| Adult and neonatal CPCs | Cardiac repair | ISS | Only neonatal CPCs showed an increased expression of early developmental markers and an enhanced proliferative potential | Baio et al |
| IMR90 iPSCs, hESCs (H7 and H9) | Progenitor cardiac spheres | RPM | Progenitor cardiac spheres (RPM) result in efficient generation of highly enriched hPSC‐CMs. Increase in proliferation and viability of CPCs | Jha et al |
| Mouse ESCs | Mouse embryo | 2D Clinostat | Deregulation of genes involved in heart development and inhibition of cardiomyocyte specific genes | Shinde et al |
| PICM‐19 | Pig liver tissue | Spaceflight, STS‐126 mission | In vitro model for assessing liver function in μ | Talbot et al |
| ADSCs | Subcutaneous adipose tissue | μ | Stemness properties, including self‐renewal and multipotency differentiation capacities, were enhanced by spheroid forma‐tion in μ | Zhang et al |
|
HepG2 Human biliary tree stem/progenitor cells (hBTSCs) | Hepatocyte carcinoma | RCCS | s‐μ | Costantini et al |
| Human epidermal stem cells (hEpSCs) | Epidermis‐like structure | RWV bioreactor, Cytodex‐3 microcarriers | hEpSCs aggregated on the microcarriers and formed multilayer 3D epidermis structures | Lei et al |
| ADSCs | Adipose tissue | 2D clinostat, CTGF | Differentiation to fibroblast cells. | Ebnerasuly et al |
Abbreviations: 2D, two‐dimensional; 3D, three‐dimensional; AD(M)SCs, adipose tissue‐derived (mesenchymal) stem cells; BMSCs, bone marrow mesenchymal stem cells; Col1, collagen type I gene; ColIII, collagen type III gene; CPCs, cardiac progenitor cells; CTGF, connective tissue growth factor; ESCs, embryonic stem cells; EPCs, endothelial progenitor cells; FLK1, fetal liver kinase 1; FSP1, fibroblast‐specific protein 1 gene; hBTSCs, human biliary tree stem/progenitor cells; HFB, hydrodynamic focusing bioreactor; MCS, multicellular spheroids; MMP1, matrix metalloproteinase 1 gene; PBMNCs, peripheral blood mononuclear cells; RCCS, rotary cell culture system; RPM, random positioning machine; RWV, rotating wall vessel; r‐μg, real microgravity; s‐μg, simulated microgravity; SOD2, superoxide dismutase 2; STLV, slow turning lateral vessel‐type rotating bioreactor; TAZ, PDZ‐binding motif; VEGF, vascular endothelial growth factor; vWF, von Willebrand factor; YAP1, yes‐associated protein 1 gene.
FIGURE 2Effects of real or simulated microgravity on stem cell cultures (lower panel) and cancer stem cells (upper panel) together with the possible applications in medicine. Arrows indicate increases/reductions. BMSC, bone marrow‐derived stem cell; CBSC, umbilical cord blood stem cell; CSC, cancer stem cell; EPC, endothelial progenitor cell; ESC, endothelial stem cell; hFOB, human fetal osteoblast; HSC, hepatic stem cell; iPSC, induced pluripotent stem cell; μg, microgravity. Parts of the figure are drawn using pictures from Servier Medical Art (https://smart.servier.com), licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0)